CAR-T cell therapy involves genetically modifying a patient's own T-cells to express a chimeric antigen receptor (CAR) on their surface. This CAR enables T-cells to recognize and bind to specific cancer cell antigens, leading to their destruction. The modified CAR-T cells are then infused back into the patient's body, where they multiply and initiate a potent immune response against cancer cells.